STAAR Surgical revamps procedures after FDA warning; product complaints at issue

February 1, 2004

Monrovia, CA-Officials at STAAR Surgical Co. are scrambling to answer questions raised by a warning letter from the FDA that criticized the company for failing to review product complaints adequately and ensure quality control of its manufacturing materials.